Clinical associations of an updated medication effect score for measuring diabetes treatment intensity
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objectives: The medication effect score reflects overall intensity of a diabetes regimen by consolidating dosage and potency of agents used. Little is understood regarding how medication intensity relates to clinical factors. We updated the medication effect score to account for newer agents and explored associations between medication effect score and patient-level clinical factors. Methods: Cross-sectional analysis of baseline data from a randomized controlled trial involving 263 Veterans with type 2 diabetes and hemoglobin A1c levels ≥8.0% (≥7.5% if under age 50). Medication effect score was calculated for all patients at baseline, alongside additional measures including demographics, comorbid illnesses, hemoglobin A1c, and self-reported psychosocial factors. We used multivariable regression to explore associations between baseline medication effect score and patient-level clinical factors. Results: Our sample had a mean age of 60.7 ( SD = 8.2) years, was 89.4% male, and 57.4% non-White. Older age and younger onset of diabetes were associated with a higher medication effect score, as was higher body mass index. Higher medication effect score was significantly associated with medication nonadherence, although not with hemoglobin A1c, self-reported hypoglycemia, diabetes-related distress, or depression. Discussion: We observed several expected associations between an updated medication effect score and patient-level clinical factors. These associations support the medication effect score as an appropriate measure of diabetes regimen intensity in clinical and research contexts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834 · cited 2×
“MES adjustment factors were initially devised based on a consensus statement by the American Diabetes Association (ADA) in 2009, which included expected HbA1c reductions with available diabetes medication classes.(24) Based on interim studies, we updated the MES by reviewing adjustment factors for older classes and in…”
BackgroundMethodEfficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368
Long-term effects of intensive glucose lowering on cardiovascular outcomes
The ACCORD Study Group (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006524 · Cited by 1,035
Phung, O. J. (2010) · JAMA · doi:10.1001/jama.2010.405 · Cited by 520
Snoek, F. J., Pouwer, F., Welch, G. W., & Polonsky, W. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1305 · Cited by 444
Hypoglycemia in Type 2 Diabetes
Zammitt, N. N., & Frier, B. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2948 · Cited by 435
Correlates of Insulin Injection Omission
Peyrot, M., Rubin, R. R., Kruger, D. F., & Travis, L. B. (2010) · Diabetes Care · doi:10.2337/dc09-1348 · Cited by 407 · cited 2×
“Notably, nonadherence increases with number of daily insulin injections, which consequently impairs attainment of goal HbA1c.(43) Therefore, despite the important role of insulin in improving glycemic control and reducing diabetes complications, the value of regimen intensification with insulin should be weighed again…”
BackgroundRiddle, M. C., Ambrosius, W. T., Brillon, D. J., Buse, J. B., Byington, R. P., Cohen, R. M., Goff, D. C., Malozowski, S., Margolis, K. L., Probstfield, J. L., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1278 · Cited by 406 · cited 1×
“Notably, the intensive control arm in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study experienced higher mortality, an effect that was concentrated in a subgroup of patients who remained “resistant” to HbA1c lowering despite protocol-driven regimen intensification.(12,13) This finding highlights t…”
BackgroundComparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial
Tay, J., Luscombe-Marsh, N. D., Thompson, C. H., Noakes, M., Buckley, J. D., Wittert, G. A., Yancy, W. S., & Brinkworth, G. D. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.112581 · Cited by 341
Self-citationCarter, S., Clifton, P. M., & Keogh, J. B. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0756 · Cited by 299
Research works printed but not linked: 32
- 10.1002/ijc.26165 · DOI · Paper page
- 10.1111/j.1742-1241.2010.02544.x · DOI · Paper page
- 10.1177/147323000203000111 · DOI · Paper page
- 10.1093/qjmed/hcm031 · DOI · Paper page
- Pollack M, 2010, J Clin Outcomes Manag, 17, 257
- 10.1016/j.jpsychores.2013.11.003 · DOI · Paper page
- 10.1007/s10865-007-9147-y · DOI · Paper page
- 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- 10.1056/NEJMoa0808431 · DOI · Paper page
- 10.1056/NEJMoa0802743 · DOI · Paper page
- 10.1111/dom.12191 · DOI · Paper page
- 10.1016/j.cct.2017.04.004 · DOI
- 10.1097/SLA.0b013e318232b033 · DOI · Paper page
- 10.2337/dc17-0303 · DOI · Paper page
- 10.2337/dc14-0845 · DOI · Paper page
- 10.3390/nu8050289 · DOI · Paper page
- Watson NA, 2015, Contemp Clin Trials, 45, 217, 10.1016/j.cct.2015.11.001 · DOI
- 10.2337/dc09-1727 · DOI · Paper page
- 10.2337/diacare.20.4.597 · DOI · Paper page
- 10.1111/dom.12174 · DOI · Paper page
- 10.1016/S0149-2918(03)80068-1 · DOI
- 10.1111/j.1463-1326.2011.01380.x · DOI · Paper page
- 10.1111/dom.12849 · DOI · Paper page
- 10.1111/dom.13361 · DOI · Paper page
- 10.1111/dom.12670 · DOI · Paper page
- 10.1089/dia.2010.0207 · DOI
- 10.1097/MLR.0b013e318269e121 · DOI · Paper page
- 10.1097/01.MLR.0000093487.78664.3C · DOI · Paper page
- 10.7326/0003-4819-154-10-201105170-00007 · DOI · Paper page
- 10.1111/dme.12128 · DOI · Paper page
- 10.1185/03007990903421994 · DOI · Paper page
- 10.1345/aph.1D479 · DOI · Paper page
Cited by
Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., & McCall, A. L. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa118 · Cited by 82
Dening, J., Mohebbi, M., Abbott, G., George, E. S., Ball, K., & Islam, S. M. S. (2023) · Nutrition & Diabetes · doi:10.1038/s41387-023-00240-8 · Cited by 31
McKenzie, A. L., Athinarayanan, S. J., Van Tieghem, M. R., Volk, B. M., Roberts, C. G. P., Adams, R. N., Volek, J. S., Phinney, S. D., & Hallberg, S. J. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111898 · Cited by 25
van den Burg, E. L., Schoonakker, M. P., van Peet, P. G., van den Akker-van Marle, E. M., Lamb, H. J., Longo, V. D., Numans, M. E., & Pijl, H. (2024) · Diabetologia · doi:10.1007/s00125-024-06137-0 · Cited by 25
Cox, D. J., Banton, T., Moncrief, M., Conaway, M., Diamond, A., Holmes, V., Green Pastors, J., Wolf, A., Fang, K., & McCall, A. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001795 · Cited by 20
Metadata
- Authors
- Alexopoulos, A.-S., Yancy, W. S., Edelman, D., Coffman, C. J., Jeffreys, A. S., Maciejewski, M. L., Voils, C. I., Sagalla, N., Barton Bradley, A., Dar, M., Mayer, S. B., & Crowley, M. J.
- Venue
- Chronic Illness
- Publisher
- SAGE Publications
- Published
- 2019-10-25
- Volume
- 17
- Issue
- 4
- Pages
- 451-462
- ISSN
- 1742-3953 (ISSN-L)
- 1745-9206
- OpenAlex
- W2981738606
- Cited by
- 44
- References
- 13
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Funders
- Health Services Research and Development (CDA 13-261, IIR 13-053, RCS 14-443)
- Durham Center of Innovation to Accelerate Discovery and Practice Transformation (CIN 13-410)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007012)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical associations of an updated medication effect score for measuring diabetes treatment intensity. https://app.cochat.ai/papers/10.1177/1742395319884096
- The paper
- Alexopoulos, A.-S., Yancy, W. S., Edelman, D., Coffman, C. J., Jeffreys, A. S., Maciejewski, M. L., Voils, C. I., Sagalla, N., Barton Bradley, A., Dar, M., Mayer, S. B., & Crowley, M. J. (2021). Clinical associations of an updated medication effect score for measuring diabetes treatment intensity. Chronic Illness. https://doi.org/10.1177/1742395319884096
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.